Neil D. Miller

Discovery of GSK2795039, a Novel Small Molecule NADPH Oxidase 2 Inhibitor

Kazufumi Hirano, Woei Shin Chen, Adeline L.W. Chueng et al. · Antioxidants and Redox Signaling · 2015 · 187 citations · Full text

2,5-Diketopiperazines as potent and selective oxytocin antagonists 1: identification, stereochemistry and initial SAR

Paul G. Wyatt, Michael Allen, Alan D. Borthwick et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 66 citations

Selective Oxytocin, Medicinal Chemistry, Drug Target +10

Procognitive 5-HT6 antagonists in the rat forced swimming test: Potential therapeutic utility in mood disorders associated with Alzheimer's disease

Kazufumi Hirano, Thomas M. Piers, Kirsten L. Searle et al. · Life Sciences · 2009 · 56 citations

Neuropsychology, Alzheimer's Disease, Psychiatry +13

Synthesis and Pharmacological Evaluation of Dual Acting Ligands Targeting the Adenosine A_2A and Dopamine D₂ Receptors for the Potential Treatment of Parkinson’s Disease

Manuela Jörg, Lauren T. May, Frankie S. Mak et al. · Journal of Medicinal Chemistry · 2014 · 51 citations · Full text

Dual Acting Molecules, Drug Target, Pharmacotherapy +18

5-HT6 receptor antagonists: prospects for the treatment of cognitive disorders including dementia.

Christopher N. Johnson, Mahmood Ahmed, Neil D. Miller · PubMed · 2008 · 46 citations

Neuropsychology, Psychopharmacology, New Generation +18